| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TNF Pharmaceuticals, Inc. | Director, Chief Medical Off., Director | Common stock | 1.08K | $97.00 | $0.09 | Oct 3, 2025 | Direct |
| TNF Pharmaceuticals, Inc. | Director, Chief Medical Off., Director | Employee Stock Option (Right to Buy) | 125K | Apr 17, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| QCLS | Q/C TECHNOLOGIES, INC. | Oct 3, 2025 | 1 | $0 | 4 | Oct 6, 2025 | Director, Chief Medical Off., Director |
| TNFA | TNF Pharmaceuticals, Inc. | Apr 17, 2025 | 1 | $0 | 4 | Apr 18, 2025 | President, CMO, Director |
| MYMD | MyMD Pharmaceuticals, Inc. | Apr 8, 2024 | 0 | $0 | 3 | May 16, 2024 | Director |